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Abstract
The genetic mechanisms involved in attention deficit hyperactivity disorder (ADHD) are being
studied with considerable success by several centres worldwide. These studies confirm prior
hypotheses about the role of genetic variation within genes involved in the regulation of dopamine,
norepinephrine and serotonin neurotransmission in susceptibility to ADHD. Despite the
importance of these findings, uncertainties remain due to the very small effects sizes that are
observed. We discuss possible reasons for why the true strength of the associations may have been
underestimated in research to date, considering the effects of linkage disequilibrium, allelic
heterogeneity, population differences and gene by environment interactions.
With the identification of genes associated with ADHD, the goal of ADHD genetics is now shifting
from gene discovery towards gene functionality – the study of intermediate phenotypes
('endophenotypes'). We discuss methodological issues relating to quantitative genetic data from
twin and family studies on candidate endophenotypes and how such data can inform attempts to
link molecular genetic data to cognitive, affective and motivational processes in ADHD.
The International Multi-centre ADHD Gene (IMAGE) project exemplifies current collaborative
research efforts on the genetics of ADHD. This European multi-site project is well placed to take
advantage of the resources that are emerging following the sequencing of the human genome and
the development of international resources for whole genome association analysis. As a result of
IMAGE and other molecular genetic investigations of ADHD, we envisage a rapid increase in the
number of identified genetic variants and the promise of identifying novel gene systems that we are
not currently investigating, opening further doors in the study of gene functionality.
Background
Research into the etiology of attention deficit hyperactiv-
ity disorder (ADHD) exemplifies the way that inter-disci-
plinary research fosters collaboration and opens up new
avenues of investigation. International research has estab-
lished that there is a strong genetically inherited contribu-
tion to ADHD and the genetic mechanisms involved are
being sorted with considerable success by several centres
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worldwide. Recent review and meta-analyses of available
data demonstrate an emerging set of findings that confirm
prior hypotheses about the role of genetic variation within
genes involved in the regulation of catecholamine neuro-
transmitters in susceptibility to ADHD [1,2]. Despite the
importance of these findings, uncertainties remain due to
the very small effect sizes that are observed, with average
odds ratios in the range of 1.1 to 1.5. Under simple addi-
tive multi-gene models it is feasible that there exist numer-
ous small genetic effects and we can estimate the
contribution of the current loci to phenotypic variance
(Table 1). Assuming an additive model, the variants iden-
tified so far explain around 3.3% of the variance, which is
only 4% of the heritable component (assuming heritabil-
ity for ADHD of 80%).
However, it is possible that the observed effects do not
reflect the true strength of the associations and we have
merely detected one or more pointers, behind which lie
larger genetic effects. Further work is required to establish
the true size of the genetic effects and to use genetic infor-
mation to refine the clinical and neurocognitive pheno-
types associated with the genetic markers. Underestimates
of effect size can arise for several reasons and a number of
difficulties exist in identifying associated genes and deriv-
ing accurate estimates of effect size using genetic associa-
tion studies. Some of the most likely causes are listed in
Table 2 and discussed in more detail below. So until we
have performed further investigations we cannot be confi-
dent that the genes identified so far do not make a more
substantial contribution. In the following sections we will
consider the effects of linkage disequilibrium, allelic het-
erogeneity, population differences and gene by environ-
ment interactions.
Linkage disequilibrium and direct versus indirect 
association
Across small intervals of the genome (10,000 – 100,000
base pairs), a phenomenon called linkage disequilibrium
(LD) is observed. LD is the non-random assortment of
alleles at two distinct loci, meaning that the genotype at a
second locus can be marginally predicted by the genotype
at the first locus. This non-random assortment gives rise to
marginal information about a second locus from the gen-
otype of a first locus. So, the genetic markers reported to
be associated with ADHD may not be the causal variants
(functionally significant variants or FSVs), but rather
nearby genetic markers that are tagging true causal vari-
ants through LD. The strength of association between tag-
ging markers (usually single nucleotide polymorphisms
or SNPs) and the causal variant is directly proportional to
r2 (the squared correlation between two markers), a com-
mon measure of LD [3]. Further information about LD
and its uses and measures are available [4-6].
Direct association is the analysis of the functional allele,
whereas indirect association is the analysis of a secondary
allele garnering marginal signal by means of LD with the
functional allele. For example, for the genes listed in Table
1 there is evidence that genetic variants associated with
ADHD in the dopamine D4 receptor gene (DRD4) and
the serotonin transporter promotor region (HTTLPR) may
alter the expression or function of the genes (reviewed in
Asherson et al., 2004 [2]). In contrast, the genetic variants
within or close to the dopamine D5 receptor (DRD5),
synaptosomal associated protein (SNAP-25), dopamine
beta-hydroxylase (DBH) and serotonin IB receptor
(5HT1B) genes are not thought to alter gene function
themselves. Rather, the variants that have been genotyped
are in LD with, and therefore tag, nearby functional
genetic changes that do alter protein structure or expres-
sion. Analysis of the dopamine transporter gene (DAT1) is
Table 1: Average odds ratios and 95% confidence (CI) from the pooled analysis of genetic variants found to be associated with ADHD 
in more than one study (Faraone et al., 2005) [1]. Quantitative trait effects are estimated for these key findings using the variance 
components 2 relative risk calculator http://pngu.mgh.harvard.edu/~purcell/gpc/vc2rr.html. This program calculates the threshold, 
assuming a standard normal trait distribution, such that the QTL variance for the discrete category based upon this threshold would 
be the same as the QTL variance for the continuous measure. Assuming an additive genetic model, the proportion of phenotypic 
variance explained by the associated genes is around 3.2%. The number of families needed to replicate these findings with a nominal 
alpha of 0.05 and 80% is listed, in addition to the power from a sample of 200 families for the same significance level.
Gene OR 95% CI Allele frequency QTL Number of families to replicate 
with 80% power
Power in sample of 200 cases 
and 200 controls
DRD4 1.16 1.03 1.31 0.12 0.001 3196 0.115
DRD5 1.24 1.12 1.65 0.35 0.004 728 0.341
DAT1 1.13 1.03 1.24 0.73 0.001 2748 0.125
DBH 1.33 1.11 1.59 0.5 0.007 391 0.561
SNAP-25 (T1065G) 1.19 1.03 1.38 0.5 0.003 1043 0.253
SERT (HTTLPR) 1.31 1.09 1.59 0.6 0.006 466 0.490
HTR1B 1.44 1.14 1.83 0.71 0.010 315 0.652Behavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
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ongoing and the functional status of the associated
marker is not yet clear [7].
The extent to which direct or indirect association is the
case for the variants hypothesized to be associated with a
disorder such as ADHD, is difficult to assess. Biological
significance cannot be declared as a result of a genetic
association study but only through functional assays [8].
However, such assays are far more expensive to run and
more difficult to interpret than genetic association. For
this reason genetic association studies aim to cull the list
of candidate variants to a likely few for biological investi-
gation. Further information about likely candidates can
be derived from haplotype analysis (the analysis of multi-
ple closely linked markers). By typing multiple markers in
a region we may be able to distill our list of suspects to a
few variants on a specific haplotype.
Association with common genetic variants or haplotypes
in ADHD has so far been interpreted to mean that a com-
mon causal variant exists that confers a small genetic risk
for ADHD. Yet it remains feasible that rare alleles, which
confer larger genetic risks in a subset of individuals, may
exist if they are correlated with the common genetic mark-
ers or haplotypes that have been identified so far. With the
exception of the dopamine D4 receptor gene [9-12], the
genes thought to be associated with ADHD have not been
fully investigated. For this reason we cannot say whether
the genetic variants associated with ADHD are likely to be
causal variants themselves or might tag common causal
variants in the region, or even rare variants with a larger
effect in a subset of individuals. The true strength of the
association can only be estimated by direct association;
this can only occur once we have a comprehensive under-
standing of how all variation affects each gene product.
As polymorphism detection efforts increase and a higher
density of genetic variants across genes become available,
the chances of typing causal variants directly, or markers
strongly correlated with such variants, is increasing (see
Figure 1 for historical overview). Groundbreaking
advances are being made in the rapid identification of
SNPs throughout the genome [13,14] and efficient geno-
typing platforms that enable simultaneous genotyping of
hundreds of thousands of SNPs are already available [15].
Haplotype association in ADHD
A haplotype refers to a specific sequence along a single
chromosome. For example, if we consider SNP markers,
each with two possible alleles (A/a, B/b, C/c, D/d, E/e, F/
f), there are 26 or 64 possible combinations along a single
chromosome. However, for markers close together and in
LD with each other (i.e. correlated with each other), there
is usually limited haplotype diversity. This means that
only certain combinations commonly occur. For example,
if we assume equal allele frequencies of 0.5, the chances
of the any single haplotype occurring (e.g. ABCDEF)
would be 1/64. However, due to limited haplotype diver-
sity we might find that 20% of chromosomes contain the
ABCDEF haplotype and another 40% of chromosomes
the AbCDef haplotype. Such markers are said to tag each
within a population, since their relationship is non-ran-
dom and they are associated with each other to form
blocks or groups of highly correlated genetic changes.
Table 2: Alternative explanations for small genetic effects in association studies of ADHD. This table lists potential explanations for 
small effect sizes in ADHD that range between 1.1 and 2.0. Studies to include or exclude each of these possibilities have yet to be 
completed, so the true size of the genetic effects remains unknown at this time.
Multiple genes of small effect Main effect sizes of individual genes are small. Genetic influences consist mainly of common alleles, each 
making a small additive contribution to genetic effects.
Allelic heterogeneity Average effect sizes of individual causal variants are small. The average effect size could be contributed by 
common variants, each conferring a small genetic effect and/or one or more rare variants conferring larger 
genetic effects.
Tagging markers (indirect association) Strength of the observed association is proportional to the correlation between the genotyped marker(s) 
and the causal variant(s). This arises since not all the markers investigated are necessarily causal variants 
themselves, but may be tagging nearby functional genetic variants. The strength of the association will 
decrease with decreasing correlation between the tagging marker and functional variant.
Tagging phenotype Strength of association is proportional to the correlation between the measured phenotype and underlying 
genetic liability. This arises since we do not know the best way to measure underlying genetic liability for a 
disorder. Phenotypic measurements are proxy variables that serve to tag the assumed underlying 
distribution of genetic risk. The strength of the association will decrease with decreasing correlation 
between the phenotypic measures and genetic liability
Interactions between adjacent loci Variants within a gene may interact with each to alter gene function. This can arise since genetic variants 
may have functional consequences that depend on variation at a second variable site. An example that has 
been proposed is an interaction between the intro 8 and 3'UTR variants in the dopamine transporter gene 
(described in text).
Higher-order interactions Main effects of individual genes may make little or no contribution to phenotypic variance. Genetic effects 
may be mediated by interaction with environment risks (gene by environment interactions) or other 
genetic loci (gene by gene interactions, referred to as epistasis).Behavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
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As an example of a haplotype association in ADHD, we
can consider recent findings from the analysis of the
dopamine transporter gene (DAT1) and ADHD [7]. Sev-
eral previous studies have documented the association of
ADHD with a repeat length polymorphism in the 3'-
untranslated region (3'-UTR) of DAT1, although averaged
Historical perspective on gene mapping in common disorders Figure 1
Historical perspective on gene mapping in common disorders. Initial studies, before DNA markers became available, relied on 
classical genetic markers such as blood or HLA types and therefore provided very limited information on a few regions of the 
human genome. The early genetic markers that used restriction enzymes to cut DNA at specific DNA sequences could identify 
sites that differed by one or more DNA bases. These restriction fragment length polymorphisms (RFLPs) were analyzed using 
a technique called Southern blotting that could identify one or a few markers at a time and was a relatively slow process. Link-
age analysis came of age with the identification of another class of genetic variants, the simple sequence repeats (SSRs) that 
commonly consist of between two to four base pairs that are repeated in variable number tandem sequences (e.g. (AC)n) and 
are found approximately one every 50 thousand base pairs (Kb) across the genome. Around 3,000 such SSRs were identified 
for the first major human genome map in the mid 1990's, whereas only 400 of such markers are required for a first pass linkage 
scan. More recently the SNP consortium was established to identify single nucleotide polymorphisms (SNPs) that occur far 
more frequently, approximately one every 500 base pairs and are therefore useful for high-density association mapping. These 
are key to current studies since association, unlike linkage, can only be detected by markers that are correlated with functional 
variants in the population and are informative over very small distances. The HapMap project was set up to genotype SNPs 
across the genome in representative populations and establish the structure of linkage disequilibrium. High-density arrays that 
can be used to genotype between 350,000 – 500,000 SNPs in a single assay are now available and provide between 65–75% 
coverage for all SNPs with a minor allele frequency greater than 0.05. Further development of 1,000,000 plus arrays will be 
able to detect all common variation across the genome.
1976
1975
1985
1990
1994
1999
2000
2001
2004
2005
2006
Classical genetic markers e.g. HLA
Southern blotting
PCR
Simple sequence repeats 
3,000 SSR map
SNP consortium
Human sequence
SNP arrays
HAPMAP
Whole genome arrays
Small multiplex families
Large multiplex families
First sib-pair studies (n=200)
Large sib-pair studies and meta-
analysis
Large scale association studies
Whole genome associationBehavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
Page 5 of 13
(page number not for citation purposes)
across studies the odds ratio is small and there is evidence
of heterogeneity [2,16]. We recently genotyped an addi-
tional repeat length polymorphism within intron 8 of the
same gene and found that in two independent popula-
tions from the United Kingdom and Taiwan, risk for
ADHD was associated with a specific combination of alle-
les at the two loci. Only chromosomes with a 10-repeat
allele in the 3-untranslated region and a 3-repeat allele in
intron 8 were associated with risk for ADHD (see Figure 2
for explanation of these terms and Figure 3 for illustration
of the haplotype specific association). Since none of the
other common allelic combinations (10/2 and 9/3) con-
ferred risk for ADHD, we concluded that either the 10/3
haplotype tags a functional variant that occurs on this
haplotype background (i.e. neither of the markers studied
so far are functional), or that there is a direct interaction
between two functional variants. We subsequently
reported a similar pattern of findings using the stage I
sample of 680 families from the International Multi-cen-
tre ADHD Gene project [17].
The DAT1 haplotype association is illustrated in Figure 3.
Although the most common explanation for these find-
ings is the existence of a common variant of DAT1 confer-
ring a small genetic risk to ADHD, it is also possible that
a rare allele exists on the background of the 10/3 haplo-
type. For example, a rare risk allele (A+) conferring a large
risk for ADHD might occur on chromosomes with the 10/
3 haplotype. The 10/3/A+ haplotype would therefore be a
relatively rare subset of all chromosomes with the 10/3
haplotype and would be associated with a large risk for
ADHD, whereas chromosomes with the alternative 10/3/
A- haplotype would confer no risk for ADHD. For these
reasons we cannot be certain of the size of the genetic
effect until the entire gene has been extensively investi-
gated by re-sequencing and identification of all potential
functional variants; either there is a small effect across the
entire sample (consistent with multiple additive genetic
effects) or a large effect in a subset of samples (consistent
with genetic heterogeneity).
Allelic heterogeneity and gene-wide tests of association
Allelic heterogeneity refers to a situation where multiple
causal variants of differing frequency and effect size exist
within a gene. Additionally, different populations may
exacerbate this problem of allelic heterogeneity, as it is
common for variation across the genome to be present or
absent, depending on the population studied. Further-
more, LD, which is derived from population history,
changes between populations [18]. The extent to which
this is the case is still unclear, but a number of studies
have observed different haplotype structures across differ-
ent populations [19-21].
For these reasons, gene-wide  testing that analyzes all
sequence variation across a gene may provide a better
frame for assessing evidence for association with a partic-
ular trait or disorder. Conceptually, there may be more
than one variant within a gene conferring risk to a disor-
der such as ADHD. A gene-wide test of association takes
this possibility into account by summing up all the evi-
dence for association with markers occurring across an
entire gene. At the same time gene-wide tests of associa-
tion adjust significance values for multiple variants span-
ning a gene. Gene-wide testing therefore aims to allay some
of the difficulties of allelic heterogeneity by allowing for
multiple association signals to contribute to a single piece
of evidence. Gene-wide tests of significance also provide a
useful framework for dealing with the vast number of tests
inherent in genome-wide association [22]. Fundamental
to a gene-based approach is a comprehensive analysis of
each gene, which requires re-sequencing in multiple indi-
Illustration of a typical protein-coding gene Figure 2
Illustration of a typical protein-coding gene. The promoter sequence regulates the process of messenger RNA (mRNA) pro-
duction. mRNA is the template from which proteins are translated by matching of amino acids to the mRNA sequence. The 
gene is divided into exons (yellow), which are the coding regions for the amino acids in the protein. The untranslated regions 
(red) are found at either end of the mRNA and have various regulatory functions affecting mRNA expression and protein 
translation; because these regions appear in the mature mRNA molecule, they are also classified as exon sequences. Introns 
(blue) are found in the primary transcript and are spliced out to form the mature mRNA molecule. Sequences flanking each 
exon direct the splicing process. Additional elements regulating mRNA production can be found both within introns as well as 
outside of the gene. Genetic variation in any of the functional regions may alter either protein structure or expression.Behavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
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viduals to identify all potential causal variants. Although
at this time re-sequencing of all potential genes associated
with ADHD is prohibitively expensive, it is envisaged that
technical developments will make such an approach fea-
sible within the next decade.
Screening candidate genes for association
The candidate gene approach has been successful in iden-
tifying several genetic variants that are associated with
ADHD. This has been largely a matter of good fortune, in
the sense that the genes investigated initially were selected
since they code for protein targets of many treatments
used in general psychiatry, including stimulants used to
treat ADHD. Such studies are, however, far from complete
and in some cases candidate genes have been prematurely
described as not associated with ADHD. This has occurred
for two main reasons.
First, sample sizes used to date are insufficient to reliably
detect small effect sizes, similar to those identified so far.
Table 1 lists the sample sizes required to replicate the most
significant findings reported to date, assuming 80%
power of detection and a nominal alpha value of 0.05. We
have also listed the amount of power at the same alpha
level to detect these genetic effects with a sample size of
200, which is similar to that used in many published stud-
ies to date. Our most recent analyses of DAT1 and the
dopamine D4 receptor gene (DRD4) in the IMAGE sam-
ple illustrate the problem. In a sample of 680 families we
just hit nominal significance for the DAT1 association,
whereas for DRD4 we required a total dataset of over
1,100 families [17]. For both associations the observed
odds ratios were very close to those reported in the meta-
analysis by Faraone et al. [1] (Table 1).
Second, few studies have taken a comprehensive approach
to the analysis of individual genes by scanning genetic var-
iation across entire gene regions. An example of a compre-
hensive gene-based approach is reported in a recent study
of the noradrenergic transporter gene (NET1) [23]. This
initial study aimed to screen the entire region spanning
NET1. This was achieved by selecting database SNPs with
minor allele frequencies greater than 5% that occurred
within known functional regions; upstream promotor
region, 5' and 3' untranslated regions, coding regions
(exons) and intron sequences flanking each exon. The var-
ious sequences that make up the DNA sequence for typical
protein coding genes are illustrated in Figure 2. Since
NET1 has not been fully sequenced in multiple individu-
als, we do not know the location of all potential func-
tional variants within the gene, which might for example
include regulator elements in non-coding regions of the
gene. Additional tagging SNPs were therefore selected,
which were predicted to tag polymorphic variants
(through LD) that are currently unknown and therefore
not available for direct association analysis. In total we
identified 26 SNPS and screened these for association
with ADHD in case and control samples. Three SNPs were
identified that showed nominal significance. Two of SNPs
that had previously been reported to show no association
with ADHD [24-26] were also negative in this study.
The small effect sizes that we observed for the three nom-
inally associated SNPs led us to conclude that, after adjust-
ment for the 26 SNPs tested, there was no evidence for
association between ADHD and NET1. In a subsequent
study, Bobb et al. [27] reported on genetic variants that
had previously been reported to show nominal associa-
tion with ADHD and found significant association with
two of the three SNPs that we had identified (rs998424
and rs3785157), although with the opposite SNP alleles.
The two markers associated with ADHD in both studies
are strongly correlated with each other, having an r-square
statistic of 0.93 in the UK sample and can therefore be
considered to tag a single genetic association. However,
despite evidence for association with the same two SNPs
in two studies, we cannot be confident in these findings
due the different directional effects of the SNP alleles. Fur-
ther studies will therefore be required to clarify whether
the SNP cluster tagged by these two markers is associated
with ADHD or whether these are merely chance observa-
tions.
Log of the odds ratios for haplotype specific associations  between ADHD and the intron 8 and 3'-UTR repeat poly- morphisms in DAT1 Figure 3
Log of the odds ratios for haplotype specific associations 
between ADHD and the intron 8 and 3'-UTR repeat poly-
morphisms in DAT1. Only chromosomes that contained the 
specific combination of the 3-repeat allele at the intron 8 
marker and the 10-repeat at the 3'-UTR marker were over-
transmitted from heterozygote parents to their affected off-
spring with ADHD (adapted from Brookes et al., 2005) [14].
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We have used a similar approach in the first set of analyses
using the IMAGE stage I dataset of 680 families. Our aim
in this study was to complete a systematic scan of genes
that are functionally related to the main candidate gene
systems identified to date. Our criteria for selection of can-
didate genes included analysis of genes with a priori evi-
dence of association with ADHD and genes involved in
the regulation of the neurotransmitter pathways impli-
cated by the previous associations. We identified a total of
52 genes that fell into the categories of brain expressed
catecholamine (dopamine, noradrenaline, serotonin)
transporters, receptors, metabolism and catabolism genes.
Additional categories included synaptic vesicle genes asso-
ciated with synaptosomal associated protein gene (SNAP-
25) and clock genes involved in regulation of circadian
rhythms. In total we identified 1,536 SNPs with reported
minor allele frequencies greater than 5% that fell within
known functional sequences or tagged common haplo-
types spanning each gene. Since some genes had a very
high proportion of non-validated SNPs, we included 230
SNPs with non-validation status, of which only 13%
turned out to be polymorphic. Of the 1,306 SNPs that
were reported to be validated, only 68% were polymor-
phic in our sample, including 91% of 556 SNPs with gen-
otypes available from Caucasian samples in the
International HapMap database [13]; HapMap is an inter-
national resource for the selection of SNPs across the
whole genome. Our final dataset included 928 polymor-
phic SNPs spanning 3,121 thousand bases pairs (kb) with
an average SNP density of 1 every 3.36 kb. Despite the
large sample size, we could only draw a few firm conclu-
sions [17]. We found nominal significance with one or
more genetic markers in eighteen genes, including the two
most replicated findings in the literature: DRD4 and
DAT1. Gene-wide tests adjusted for the number of mark-
ers studied in each gene identified associations with
TPH2, ARRB2, SYP, DAT1, ADFRB2, HES1, MAOA and
PNMT. Further studies will be needed to confirm or refute
the observed associations.
Gene by environment interactions
To date most genetic studies in ADHD have focused on
the detection of genetic variants that have a main effect on
the risk for behavioural disorders. However, it has been
recognized for a long time that gene-environment interac-
tions are likely to play an important role on risk for behav-
iour and in some cases will be present in the absence of
main effects. What is not widely understood is that the
heritable component estimated from family, twin and
adoption studies indexes both the main effects of genes
plus the effects of gene-environment interaction. For this
reason environmental research remains critical to our
understanding of psychiatric disorders, even for those that
are highly heritable such as ADHD.
An emerging literature on the effects of gene-environment
interactions on behavioural disorders and an outline of
the methodological issues has recently been reviewed
[28]. Using a longitudinal population sample from Dun-
edin in New Zealand, Caspi, Moffitt and colleagues
reported three key findings. First they hypothesized that a
functional polymorphism in the promoter region of the
gene encoding the neurotransmitter metabolizing enzyme
monoamine oxidase A (MAOA), would moderate the
effect of child maltreatment in the cycle of violence. Their
results showed that maltreated children with genotypes
that conferred low levels of MAOA expression were more
likely to develop conduct disorder, antisocial personality
disorder and adult violent criminal behaviour than chil-
dren possessing high activity variants of MAOA [29]. In
the second study they hypothesized that a functional var-
iant in the promoter region of the serotonin transporter
gene (HTTLPR) would moderate the influence of stressful
life events on depression. They found that individuals
with 1 or 2 copies of the HTTLPR short allele exhibited
more depressive symptoms, diagnosable depression, and
suicidality following stressful life events than individuals
homozygous for the long allele [30]. This finding has
been replicated in several further studies and is now one
of the most consistent findings in psychiatric genetics [31-
33]. In the third study they reported that a functional var-
iant of the catechol-O-methyltransferase gene (COMT
Val158Met) would moderate the risk of cannabis use by
adolescents on the later development of psychosis in
adult life [34].
These three findings highlight the importance of consider-
ing the effects of environmental exposure in the search for
genetic risk factors. Moffitt, Caspi and Rutter noted several
important methodological points in their review [28].
First, they noted that several of their initial reports were
subsequently replicated, indicating the robust nature of
some G × E interactions on human behaviour. Second,
that in each case the environmental risk involved had
shown an association with the disorder in previous epide-
miological studies. In other words, they were known envi-
ronmental pathogens. Third, in several of the reports it
was noted that there was no main effect of gene alone.
This has important implications since the search for
genetic associations with behavioural disorders would
have been unsuccessful in these examples if interaction
with the environmental pathogen had not been taken into
account. These findings have promoted a new wave of
interest in gene-environment research, although identify-
ing such interactions remains a major challenge. Unlike
the DNA variation, where we know that we will soon be
able to scan the entire human genome for associated
genetic variants, environmental research will depend on
careful selection of appropriate and measurable environ-
mental risks. Information ascertainment on environmen-Behavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
Page 8 of 13
(page number not for citation purposes)
tal risk factors will present particular methodological
challenge, as prospective cohort studies are likely to con-
tain too few ADHD cases for meaningful analysis, while
retrospective recall data on risk exposure in case and con-
trol design is likely to be confounded by recall bias. It is
therefore particularly timely to examine the genetic contri-
bution of ADHD quantitative traits amongst subjects from
prospective cohorts, as well as gathering retrospective data
of risk exposure in ADHD cases. Convergence of evidence
from both prospective and retrospective data can then
provide cross validation of findings from both strategies.
Nevertheless, this will be necessarily a time consuming
and costly process and requires reasonable prior hypothe-
ses to be generated.
Once a specific gene-environment interaction has been
identified, the next set of questions is to clarify the precise
mechanisms involved. This is not always immediately
obvious, since apparent interactions with an environmen-
tal variable may have several causes, including the possi-
bility that scaling effects in the outcome measure can give
rise to statistical interactions when the true mechanism is
a simple additive effect [35].
As an example in ADHD research we consider the recent
report of an interaction between the mothers use of alco-
hol during pregnancy and genetic variants of the
dopamine transporter gene (DAT1) on the risk for devel-
opment of childhood ADHD [7]. In this study only those
individuals carrying the DAT1 risk alleles whose mothers
used alcohol during the pregnancy showed an increased
risk for ADHD. Yet there are several plausible explana-
tions for this observation. First, there may be a direct toxic
effect of alcohol on the developing fetus. Further work to
establish this causal link needs to focus on more detailed
analysis that considers the timing and amount of alcohol
used by mothers during the pregnancy. However, other
causal relationships need to be considered since maternal
drinking may be correlated with parental behaviours that
could act as more proximal risk factors, such as levels of
critical comments, quality of parenting and maternal psy-
chopathology including ADHD. Interactions with varia-
bles that reflect parental behaviour may also index genetic
loading consistent with the increased co-transmission of
interacting genes (gene-gene interaction also referred to as
epistasis). For example, in this study we also found pre-
liminary evidence for gene-environment correlation
between the DAT1 risk alleles and prenatal use of alcohol.
Although we controlled for this in our analysis, it high-
lights the complexity of interpreting gene-environment
effects where genes cause change in parent as well as off-
spring behaviour. Well-designed epidemiological studies
are one approach, but direct testing of environmental
hypotheses may require the use of animal behavioural
and genetic models and a focus on more direct neurobio-
logical measures of brain function in addition to the anal-
ysis of behavioural phenotypes.
'Tagging phenotypes'
The term 'tagging phenotype' refers to the fact that the
measures of ADHD used in genetic studies, such as DSM-
IV diagnosis or symptom checklists, are unlikely to map
directly onto the underlying distribution of genetic liabil-
ity. The strength of the correlation between the measures
used and genetic liability will therefore contribute to
reduced estimates of genetic effect sizes. For this reason it
has been argued that 'endophenotypes' (see below) that
are thought to be more direct measures of brain processes
than behavioural phenotypes might correlate more
strongly with genetic risk factors for ADHD. Yet we cannot
take this assumption for granted; evidence is as yet lack-
ing. At this stage we advocate the use of cognitive endo-
phenotypes to delineate the causal pathways that mediate
genetic effects on behaviour, as discussed below, rather
than their use as primary gene mapping tools.
Cognitive endophenotypes
The term 'endophenotype' was adopted for use in psychi-
atric research by Gottesman and colleagues [36,37], who
proposed the following criteria: (1) The endophenotype is
associated with illness in the population; (2) The endo-
phenotype is heritable; (3) The endophenotype is prima-
rily state-independent (manifests in an individual
whether an illness is active or not); (4) Within families,
endophenotype and illness co-segregate, and (5) The
endophenotype found in affected family members is
found in non-affected family members at a higher rate
than in the general population.
With the primary emphasis on delineating causal path-
ways, the study of cognitive endophenotypes represents a
second stage in molecular genetic research on ADHD:
once genetic associations are identified in the IMAGE and
other ADHD samples, the functionality of the risk genes –
the mechanisms by which the genes increase the risk for
the disorder – becomes a key research focus. Such investi-
gation of the cognitive and motivational processes in
ADHD within a genetic design is at its early stages (for
reviews of initial findings, (see [38-41]). For future
progress, a careful selection of cognitive-experimental
measures based on theory-driven phenotypic and quanti-
tative genetic investigations is recommended.
Here, we discuss methodological issues relating to quanti-
tative genetic data from twin and family studies on candi-
date endophenotypes and how such data can inform
attempts to link molecular genetic data to cognitive, affec-
tive and motivational processes in ADHD. Processes that
have been proposed to be affected in ADHD include state
regulation, response inhibition, working memory, aspectsBehavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
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of attention, temporal processing, 'delay aversion' and
reward processing [42,43]; a consensus is yet to emerge on
detailed aspects of the theoretical arguments.
Estimating heritability and familiality
Gottesman and colleagues [36,37] included heritability as
the second criterion in their list endophenotype criteria.
As a clear distinction has not always been made between
the terms 'heritability' and 'familiality', we first describe
how such estimates are obtained.
A twin design is required to estimate heritability [44]. The
logic behind quantitative genetic analyses of twin data has
three parts. First, monozygotic (MZ) twins share all their
inherited parental chromosomes and are therefore genet-
ically identical, whereas dizygotic (DZ) twins, like ordi-
nary full siblings, share on average only half of their
parental chromosomes and therefore 50% of inherited
genetic variation. For shared environmental influences
MZ and DZ twins are expected to correlate to the same
extent. As such, when the similarity of MZ twins is greater
than the similarity of DZ twins, this indicates a genetic
contribution to the behaviour being measured. In model
fitting, this yields a 'narrow sense' heritability estimate
(additive genetic variance). Second, if only genes were
influencing their behaviour, MZ twins' behaviour should
be at least twice as similar as DZ twins'. If, however, DZ
twin pairs are less than twice as similar as MZ twin pairs,
this indicates that environments the children share in
common have enhanced their similarity. In model fitting,
this yields an estimate for shared environmental variance.
Third, if MZ twins, despite sharing all their genes, are not
perfectly identical in their behaviour, this indicates that
experiences unique to each twin have reduced the twins'
behavioural similarity or the possibility of measurement
error. In model fitting, this yields an estimate for child-
specific environmental variance, which also includes
measurement error.
The key difference between twin and sibling designs is
that, whereas twin design produces the three estimates –
heritability, shared environmental influences and child-
specific environmental influences – sibling designs can-
not distinguish between genetic influences (heritability)
and shared environmental influences: 'familiality' reflects
the combination of genetic and shared environmental
effects.
Heritability and familiality of candidate endophenotypes 
in ADHD
The cognitive-experimental variables that indicate signifi-
cant heritability or familiality are targets for molecular
genetic investigations. The existing twin and family data
on measures of attention and executive functions were
recently reviewed by Doyle et al [41].
A key methodological limitation in several of the previous
twin studies relates to small sample sizes and therefore
limited statistical power. Studies with somewhat larger
sample sizes suggest a moderate degree of heritability for
several measures of reaction time, working memory and
general executive function performance [45-50]. We
reported twin model fitting data at the Eunethydis 2005
meeting from 400 twin pairs on a go/no-go task, a reac-
tion time task ('fast task'), digit span backwards and a
'delay aversion' task. Several key measures of reaction
time, inhibition and working memory performance indi-
cated a moderate degree of genetic influence [51]. These
tasks are also being applied to a large sub-set of the
IMAGE sample.
Yet we also demonstrated how the true extent of genetic
influences may have been underestimated, due to possi-
ble effects on analyses from measure unreliability [51]
(see also Luciano et al., [49]). This is because test-retest
reliability sets an upper limit for the heritability estimates.
Even a high test-retest reliability of .8 indicates that 20%
of the variance cannot be accounted for; in twin model fit-
ting the 20% would be 'added' to the variance component
that reflects a combination of child-specific environmen-
tal influences and measurement error, hence deflating the
heritability estimate (and possible shared environmental
estimate). Given that many cognitive-experimental meas-
ures have at best moderate-to-good reliability (see, for
example, Kuntsi et al., [52], caution is required when
interpreting heritability estimates, especially across stud-
ies, if test-retest data are not available. A combination of
test-retest reliability data and twin model fitting data can
provide information on variables that will have maxi-
mum reliability and therefore maximum sensitivity to
genetic individual differences [51].
Multivariate quantitative genetic analyses
Beyond the initial requirement of heritability or familial-
ity, an endophenotype for ADHD also needs to show
shared genetic or familial influences with those on ADHD.
This can be investigated using multivariate quantitative
genetic analyses.
In multivariate twin analysis, MZ and DZ correlations are
compared across traits: that is, one twin's scores on the first
trait are correlated with the co-twin's scores on the second
trait. If the cross-trait twin correlations are greater for MZ
than for DZ twins, this implies shared genetic influences
on the two traits. A genetic correlation (rA) indicates the
extent to which genetic influences on one trait overlap
with those on another trait (regardless of their individual
heritabilities). Based on the genetic correlation and the
individual heritability of each trait, the extent to which
shared genetic influence generates the phenotypic correla-
tion between the traits can be estimated.Behavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
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In a sibling design, significant within-individual cross-
trait correlations are indicative of common etiological
influences on the traits; significant cross-sibling cross-trait
correlations imply that these common etiological influ-
ences are familial. Where mean scores on a trait, such as a
cognitive ability, are available from probands, their (unse-
lected) siblings and controls, the extent of shared familial
effects on the proband selection variable (such as ADHD)
and the second trait (such as cognitive ability) can also be
quantified using group familial correlation. This bivariate
index, which varies between 0 and 1, indicates the extent
to which the scores of the siblings on the second trait
regress away from the population mean and towards the
proband mean. Alternatively, if adopting a binary
approach, the extent to which 'unaffected' siblings of
probands show the second trait (such as poor perform-
ance on a cognitive task) can be studied as an indicator of
an endophenotype.
Initial data suggest shared genetic or familial effects on
ADHD and response variability and aspects of executive
function performance. The finding on shared genetic/
familial effects on ADHD and response variability was
first suggested by our small-scale twin study [53] and has
subsequently been replicated in an independent family
study [54] as well as, most recently, in a sub-set of the
IMAGE sample (unpublished data). Further possible
shared familial effects with ADHD have been indicated for
performance on tasks measuring inhibition and set shift-
ing [55,54].
Multivariate quantitative genetic analyses can also be used
to investigate the extent of shared genetic influences
across multiple cognitive-experimental variables. Such
analyses can be informative, both theoretically regarding
possible causal pathways, and in guiding molecular
genetic analyses. If meaningful composite scores can be
created, these are likely to have increased reliability com-
pared to the original scores. Such composite scores would
also help reduce the need for multiple comparisons
within a molecular genetic investigation.
The IMAGE project
These are exciting times in the world of human molecular
genetics. The sequencing of the human genome in 2000
has been rapidly followed by the development of interna-
tional resources for whole genome association analysis.
Micro-array technology is already available for the simul-
taneous analysis of 500,000 SNP markers across the
human genome and these resources will be further devel-
oped in years to come.
The International Multi-centre Gene (IMAGE) project is
well placed to take advantage of these emerging resources.
The IMAGE sample consists of a European multi-site
project with a final projected dataset of 1,400 families.
Clinical data and cryopreserved lymphocytes or estab-
lished cell lines are deposited at Rutgers University, to
ensure the dataset will be available to international inves-
tigators now and in the future. The overall aim of the
IMAGE project is to take a systematic approach to screen-
ing the genome for novel genes and gene systems using a
combination of categorical and quantitative trait
approaches to linkage and association. This dual
approach is well supported by recent findings that suggest
the existence of genes of moderate effect size (e.g. odds
ratios > 3) co-acting with multiple genes of small effect
(e.g. odds ratio < 3). A quantitative trait locus genome
linkage scan is planned for summer 2006, which we pro-
pose to follow with genome association studies using the
latest generation of high-density SNP arrays.
The sample consists of European Caucasian subjects
recruited from twelve specialist clinics in eight countries:
Belgium, Germany, Holland, Ireland, Israel, Spain, Swit-
zerland and United Kingdom. The initial stage I sample
consists of 680 DSM-IV combined type probands with
808 siblings, of which 102 also had combined type
ADHD, making a total of 782 affected individuals. Since
we evaluated all available siblings, which included 102
combined type probands from 808 siblings recruited into
the study, we estimated the λs value (risk to siblings/pop-
ulation prevalence) for combined subtype to be around
6%, using the population prevalence estimates from a
recent survey in the United Kingdom [56]; a similar esti-
mate to that reported in dizygotic twins by Todd et al.
[57]. Although the DSM diagnostic criteria were not
designed to be genetically homogeneous categories, the
analysis from Todd and colleagues suggests that DSM-IV
combined type ADHD may be a genetically homogeneous
subgroup, since this subtype falls within a single empiri-
cally derived latent class that shows high levels of subtype
concordance in monozygotic and dizygotic twin pairs.
Although the IMAGE sample is a relatively large clinical
sample, we have seen that association signals have been
very small. For this reason we should expect that at a
genome-wide level, positive association signals will still
not stand out above the background distribution of asso-
ciation findings. Larger scale collaborative projects will
therefore be required if we are to find many of the genes,
particularly those that fall within novel genes and gene
systems, that influence risk for ADHD. We (and others)
therefore aim to establish international collaborations to
generate the very large datasets, in the order of two to five
thousand samples, for whole genome analysis.
Concluding remarks and future directions
As a result of these new studies, we envisage a rapid
increase in the number of identified genetic variants asso-Behavioral and Brain Functions 2006, 2:27 http://www.behavioralandbrainfunctions.com/content/2/1/27
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ciated with ADHD and the promise of identifying novel
gene systems. The size of the genetic effects ADHD identi-
fied to date are small, although as we have discussed in
some cases these may be tagging larger effects. Translation
of these effect sizes into 'real world significance' is difficult
to determine in advance of completing the task of gene
identification. Clearly, if one or more genetic variants are
identified with a large influence on risk for ADHD, these
might play a key role in diagnostic prediction and forming
targets for drug development.
However, it is entirely feasible that larger genetic effects
will not be identified and the risks from any single genetic
variant will be small and have little predictive value on
their own. In this scenario diagnostic predictions would
likely be expressed as a probability depending on the
additive effects of multiple genetic variants. It is, however,
expected that the additive effects of genes will compro-
mise the function of only one or a few neurobiological
pathways, and the identification of even small genetic
effects will help to identify the key pathways involved,
thereby identifying novel systems for drug discovery and
investigation of critical interactions with environmental
risks. Clearly the current data implicate genetic variation
of dopamine pathways in the etiology of ADHD, although
this finding was predicted in advance of the genetic stud-
ies and does not therefore come as a great conceptual
advance in the field. The key additional question is
whether genetic approaches that do not rely on a priori
hypotheses will uncover novel genes and neurodevelop-
mental processes that had not been previously consid-
ered. Furthermore, by linking genetic findings to direct
neurobiological markers of brain function using cognitive
neuroscience and direct experimentation on model sys-
tems, the effects of genetic variation associated with
ADHD on brain function can be better understood.
We therefore conclude that with the identification of
known genes associated with ADHD, the goal of ADHD
genetics is now shifting from gene discovery towards gene
functionality, at the level of molecular mechanisms and
brain processes, and a focus on interaction with environ-
mental pathogens [58]. Quantitative genetic studies have
led to a perceptual shift where ADHD is perceived as one
or more quantitative traits that share genetic influences
with other developmental, behavioural and cognitive
traits; gene identification will shed further light on the
mechanisms involved. In the study of psychiatric and
behavioural disorders, molecular genetic studies have
already confirmed a priori hypotheses for some disorders
and identified novel genes for others, and identification of
many additional behavioural genes is expected in the
coming decade. Combining genetic, environmental and
neurobiological research strategies has the potential to
delineate the causal links between behavioural traits, psy-
chiatric conditions and developmental course, including
the persistence/desistance of psychiatric symptoms and
co-morbidity between psychiatric disorders and traits. As
a result, we can look forward to new insights and potential
advances in our treatment of ADHD throughout the
lifespan.
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